Monitoring Tissue Perfusion in Critically Ill or High-risk Surgical Patients: a Pilot Clinical Study To Evaluate the aPplicability and the Safety of Urethral Perfusion Measurement With the IKORUS System
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- High-risk Surgical Patients
- Sponsor
- Advanced Perfusion Diagnostics
- Enrollment
- 30
- Locations
- 4
- Primary Endpoint
- Incidence of complications
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Circulatory shock is defined as an imbalance between oxygen supply and/or impaired oxygen use to maintain organ function. With growing evidence of lack of correlation between macro- and micro-circulation, use of "Whole Body" markers such as blood pressure (BP) or Lactates are often insufficient to assess the severity of the oxygen debt and/or tissue hypoperfusion. Thus, an approach incorporating tissue-perfusion based endpoints would represent a significant step up to guide optimal resuscitation of critically-ill patients and to reduce complications in high-risk surgery.
Current monitoring techniques, that complement systemic hemodynamics by focusing on regional perfusion, still lack the required user-friendliness and/or clinical relevance to be routinely used at bedside. Therefore, assessment of the adequacy of tissue perfusion and oxygenation is suboptimal, and implementation of the above-mentioned approaches of resuscitation is still a challenge.
Urethral perfusion is likely to be early and significantly impaired during low-flow states and thus represents a good "candidate" as a surrogate site to assess the perfusion of visceral organs. Besides, urethral mucosa can be investigated in a less invasive and simpler manner than "deeper" organs. Nowadays, no practical methods or devices are available to monitor perfusion in the pelvic area. Thus, recent development of a new monitoring device of urethral perfusion could fill this need and enable enhanced management of patients in Intensive Care Units (ICU) and Operating Rooms (OR).
The device consists of a modified Foley catheter equipped with a photoplethysmographic sensor: the IKORUS UP probe.
The probe will be used by intensivists or anesthesiologists on high-risk surgical patients, i.e. patients with comorbidities undergoing major vascular, thoracic and/or abdominal surgery.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Incidence of complications
Time Frame: 28 days
Complications rate: Injury during insertion; Bleeding; Infection; Pain; Discomfort.
Secondary Outcomes
- Signal acquisition(28 days)
- Evolution of SpO2(28 days)
- Evolution of SVO2(28 days)
- Evolution of central venous pressure(28 days)
- Evolution of mean arterial pressure(28 days)
- Evolution of catecholamine infusions levels(28 days)
- Effect of the position of the sensor(28 days)
- Evolution of lactates dosages(28 days)
- Evolution of cardiac outputs(28 days)
- Applicability of the procedure(28 days)
- Quality of the signal(28 days)
- Rate of resuscitation events(28 days)